BT-06 PLK1 AS A POTENTIAL THERAPEUTIC TARGET FOR DIPG

समान संसाधन

• MB-26 TARGETING MEDULLOBLASTOMA WITH A NEW SMALL-MOLECULE DRUG THAT INHIBITS MYC MEDIATED TRANSLATION
  द्वारा: Foreman, Bronwen, और अन्य
  प्रकाशित: (2015)
• MB-22 CHECKPOINT KINASE 1 EXPRESSION IS AN ADVERSE PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-DRIVEN MEDULLOBLASTOMA
  द्वारा: Prince, Eric, और अन्य
  प्रकाशित: (2015)
• AT-04 TARGETING Myc DRIVEN TRANSCRIPTIONAL OUTPUT IN ATYPICAL TERATOID RHABDOID TUMOR
  द्वारा: Alimova, Irina, और अन्य
  प्रकाशित: (2015)
• AT-07 PLK1 AS A THERAPEUTIC TARGET IN ATRT
  द्वारा: Alimova, Irina, और अन्य
  प्रकाशित: (2016)
• IM-08 INFLAMMATION DRIVER, NF-kB, IS ASSOCIATED WITH POOR OUTCOME GROUP A EPENDYMOMA AND REGULATES A KEY IMMUNE SUPPRESSIVE SIGNALING PATHWAY INVOLVED IN THE TUMOR MICROENVIRONMENT
  द्वारा: Griesinger, Andrea, और अन्य
  प्रकाशित: (2015)